The cure for cancer......could not have come at a better time.
I was hoping that the "optimized" (but really, correct) treatment would yield better results than those seen in the original 12 undertreated patients, and it has.
These results point to the possibility of TLT's treatment becoming the standard, as it is a) non-toxic and b) highly effective.
Nothing prevents a physician from choosing repeat treatments.
The study limits treatment to 2 sessions. For scientific purposes, all must have the same number of treatments and a larger pool of patients gives better statistical granularity.
But in real life, you can just keep treating intil the cancer responds and/or goes away completely.
Think of the bladders that could be saved!
Not just excited for my pocketbook. I'm thinking now of Gebremeskel and other posters who have shown up here telling us of their struggle against bladder cancer.
Crossing my fingers that they can find their way into this study soon.
And this bodes oh-so-well for pending studies for other cancer indications... glioblastoma, lung, etc.
All-in-all, a breakthrough in my books!
Let's see if the FDA agrees, and how quickly they do so.
It's going to be a great holiday season.